What Analysts Are Saying About Mosaic Stock
Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Mosaic (NYSE:MOS)…
Analyst Scoreboard: 7 Ratings For Staar Surgical
Staar Surgical (NASDAQ:STAA) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from…
A Closer Look at 13 Analyst Recommendations For Trade Desk
In the latest quarter, 13 analysts provided ratings for Trade Desk (NASDAQ:TTD), showcasing a mix of bullish and…
Deep Dive Into KKR Stock: Analyst Perspectives (9 Ratings)
In the preceding three months, 9 analysts have released ratings for KKR (NYSE:KKR), presenting a wide array of…
Where Paycor HCM Stands With Analysts
Ratings for Paycor HCM (NASDAQ:PYCR) were provided by 12 analysts in the past three months, showcasing a mix…
7 Analysts Assess TeraWulf: What You Need To Know
Ratings for TeraWulf (NASDAQ:WULF) were provided by 7 analysts in the past three months, showcasing a mix of…
Citigroup Analyst Sees Limited Near-Term Upside For American Express Despite Positive Long-Term Outlook – Here’s Why
Citigroup analyst initiates coverage of American Express with Neutral rating and $250 price target. Strong management, but limited near-term upside.
JP Morgan Downgrades Cleveland-Cliffs: Rising Capex And Modest Auto Demand Hamper Growth Prospects
CLF stock downgraded by JP Morgan to Neutral with lower price target. Reduced price forecasts, weak EV demand, but strong long-term prospects.
Eli Lilly’s Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst
Eli Lilly's donanemab for Alzheimer's disease garners positive FDA committee verdict, prompting analyst's bullish outlook amid comparisons to Biogen's Leqembi.
Nvidia Stock Split Might Not Lead To Sustained Rally, But It Could Replace Intel In Dow Index
Goldman Sachs cautions against expecting sustained rally after Nvidia's 10-for-1 stock split. Past splits show minimal impact on shares and liquidity.